Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Hogendorf

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neurochemical Research|June 4, 2024
Neuroprotective and Neurite Outgrowth Stimulating Effects of New Low-Basicity 5-HT<sub>7</sub> Receptor Agonists: In Vitro Study in Human Neuroblastoma SH-SY5Y CellsKlaudia Jakubowska, Adam S Hogendorf, Sławomir Gołda, et al.
Expert Opinion on Therapeutic Patents|August 21, 2018
5-HT1A receptor ligands and their therapeutic applications: review of new patentsJakub Staroń, Ryszard Bugno, Adam S Hogendorf, et al.
Chemical Science|May 21, 2025
Widespread false negatives in DNA-encoded library data: how linker effects impair machine learning-based lead predictionAlba L Montoya, Adam S Hogendorf, Steven Tingey, et al.
RSC Advances|May 11, 2022
The effect of the intramolecular C-H⋯O interactions on the conformational preferences of bis-arylsulfones - 5-HT<sub>6</sub> receptor antagonists and beyondJustyna Kalinowska-Tłuścik, Jakub Staroń, Anna Krawczuk, et al.
Medchemcomm|December 21, 2018
Search for a 5-CT alternative. <i>In vitro</i> and <i>in vivo</i> evaluation of novel pharmacological tools: 3-(1-alkyl-1<i>H</i>-imidazol-5-yl)-1<i>H</i>-indole-5-carboxamides, low-basicity 5-HT<sub>7</sub> receptor agonistsGniewomir Latacz, Adam S Hogendorf, Agata Hogendorf, et al.
European Journal of Medicinal Chemistry|May 28, 2021
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamineJakub Staroń, Wojciech Pietruś, Ryszard Bugno, et al.
European Journal of Medicinal Chemistry|December 17, 2020
Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic 5-HT<sub>6</sub>R ligands binding modeJakub Staroń, Ryszard Bugno, Wojciech Pietruś, et al.
Molecules (Basel, Switzerland)|August 7, 2021
<i>N</i>-Skatyltryptamines-Dual 5-HT<sub>6</sub>R/D<sub>2</sub>R Ligands with Antipsychotic and Procognitive PotentialAgata Hogendorf, Adam S Hogendorf, Rafał Kurczab, et al.
Scientific Reports|May 6, 2017
Low-basicity 5-HT<sub>7</sub> Receptor Agonists Synthesized Using the van Leusen Multicomponent ProtocolAdam S Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry|November 18, 2019
Virtual screening-driven discovery of dual 5-HT<sub>6</sub>/5-HT<sub>2A</sub> receptor ligands with pro-cognitive propertiesJakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurochemical Research|June 4, 2024
Neuroprotective and Neurite Outgrowth Stimulating Effects of New Low-Basicity 5-HT<sub>7</sub> Receptor Agonists: In Vitro Study in Human Neuroblastoma SH-SY5Y CellsKlaudia Jakubowska, Adam S Hogendorf, Sławomir Gołda, et al.
Expert Opinion on Therapeutic Patents|August 21, 2018
5-HT1A receptor ligands and their therapeutic applications: review of new patentsJakub Staroń, Ryszard Bugno, Adam S Hogendorf, et al.
Chemical Science|May 21, 2025
Widespread false negatives in DNA-encoded library data: how linker effects impair machine learning-based lead predictionAlba L Montoya, Adam S Hogendorf, Steven Tingey, et al.
RSC Advances|May 11, 2022
The effect of the intramolecular C-H⋯O interactions on the conformational preferences of bis-arylsulfones - 5-HT<sub>6</sub> receptor antagonists and beyondJustyna Kalinowska-Tłuścik, Jakub Staroń, Anna Krawczuk, et al.
Medchemcomm|December 21, 2018
Search for a 5-CT alternative. <i>In vitro</i> and <i>in vivo</i> evaluation of novel pharmacological tools: 3-(1-alkyl-1<i>H</i>-imidazol-5-yl)-1<i>H</i>-indole-5-carboxamides, low-basicity 5-HT<sub>7</sub> receptor agonistsGniewomir Latacz, Adam S Hogendorf, Agata Hogendorf, et al.
European Journal of Medicinal Chemistry|May 28, 2021
Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamineJakub Staroń, Wojciech Pietruś, Ryszard Bugno, et al.
European Journal of Medicinal Chemistry|December 17, 2020
Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic 5-HT<sub>6</sub>R ligands binding modeJakub Staroń, Ryszard Bugno, Wojciech Pietruś, et al.
Molecules (Basel, Switzerland)|August 7, 2021
<i>N</i>-Skatyltryptamines-Dual 5-HT<sub>6</sub>R/D<sub>2</sub>R Ligands with Antipsychotic and Procognitive PotentialAgata Hogendorf, Adam S Hogendorf, Rafał Kurczab, et al.
Scientific Reports|May 6, 2017
Low-basicity 5-HT<sub>7</sub> Receptor Agonists Synthesized Using the van Leusen Multicomponent ProtocolAdam S Hogendorf, Agata Hogendorf, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry|November 18, 2019
Virtual screening-driven discovery of dual 5-HT<sub>6</sub>/5-HT<sub>2A</sub> receptor ligands with pro-cognitive propertiesJakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
Pageof 2